Streetbeat News

Products Services

VKTX

Viking Therapeutics released positive Phase 1b trial results for VK0214, a drug for X-linked adrenoleukodystrophy (X-ALD), showing safety and efficacy in reducing disease biomarkers. This development could expand Viking's revenue streams into the rare disease market.

Portfolio Pulse from Vandana Singh

October 09, 2024 | 2:11 pm

AMZN

RIVN

Amazon plans to deploy 1,000 electric delivery vans from Rivian by early 2025, featuring vision-assisted package retrieval and internal lighting to guide deliverers to the correct packages.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:07 pm

AMZN

Amazon has introduced AI-powered shopping guides on its main site, aiming to assist users in selecting products from new categories. This move is part of Amazon's strategy to enhance user experience and streamline the shopping process.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 2:06 pm

USDC

VanEck has launched a $30 million early-stage fund, VanEck Ventures, targeting fintech, digital assets, and AI startups. The fund will focus on pre-seed and seed-stage companies, leveraging VanEck's history of recognizing transformative opportunities. Led by experienced investors Wyatt Lonergan and Juan Lopez, the fund aims to invest in category-defining founders using emerging technologies like blockchain and AI.

Portfolio Pulse from Ivan Crnogatić

October 09, 2024 | 2:04 pm

TIGR

Deep-pocketed investors are showing a bearish sentiment towards UP Fintech Holding (NASDAQ:TIGR), with 61% of options activity being bearish. This unusual activity suggests potential significant market movements. The stock is currently down by 11.57% at $8.51, with an earnings announcement expected in 47 days.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:02 pm

TSLA

Analyst Ming-Chi Kuo suggests that Tesla's upcoming robotaxi event may not lead to a significant short-term rally in TSLA stock, as mass production is expected in 1Q27. The focus is on Tesla's FSD technology meeting government requirements for Level 4 autonomy.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:48 pm

BIDU

Baidu (NASDAQ:BIDU) has seen a surge in options trading activity, with a mix of bullish and bearish sentiment among investors. The trading volume and open interest suggest a focus on a price range between $50 and $140. Despite a recent price drop, Baidu remains a key player in China's internet search market and is expanding into AI and autonomous driving.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 1:45 pm

CGC

Canopy Growth Corporation has expanded its U.S. presence by acquiring Wana, a top edibles brand, through its subsidiary Canopy USA. This acquisition, along with a majority stake in Jetty, positions Canopy USA for growth in the U.S. cannabis market. The strategy focuses on brand expansion and leveraging partnerships rather than heavy investment in cultivation.

Portfolio Pulse from Jelena Martinovic

October 09, 2024 | 1:42 pm

BAX

Baxter is increasing the allocation levels of high-demand IV fluids for direct customers and distributors in the U.S. This change will be effective from October 9, 2024, as per an SEC filing.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:32 pm

VRNOF

Verano Holdings CEO George Archos discusses the potential rescheduling of cannabis from Schedule I to Schedule III, which could significantly impact the industry by removing tax burdens and enabling further reforms like banking access. Archos emphasizes Verano's adaptability in navigating fragmented regulations and highlights the company's mission driven by personal experiences with cannabis. Verano's hospitality approach in its retail stores is seen as a competitive advantage.

Portfolio Pulse from Franca Quarneti

October 09, 2024 | 1:27 pm